New York Times contributor’s real gripe with Ozempic: It treats obesity like it’s a problem

Published



Despite the consensus of the medical community (and apparently Hollywood) that drugs such as Ozempic and Wegovy are a panacea for shedding extra pounds, Virginia Sole-Smith over at the New York Times isn’t so sure.

Is her issue that the increasing surgical and medical treatment of childhood obesity ignores underlying causes, such as a deluge of processed, sugar-infused foods or microplastics poisoning society? Or is it that, as witnessed by celebrities whittling down to the heroin chic of the 1990s, doctors might let patients with clear body dysmorphia or eating disorders take semaglutide too far? Or is it the side effects of such drugs, which haven’t even been on the market for a decade yet?

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.